11025470Sandler ES, Hagg R, Coppes MJ, Mustafa MM, Gamis A, Kamani N, Wall DMedical and pediatric oncologyAntineoplastic Combined Chemotherapy Protocols; Hematopoietic Stem Cell Transplantation; Leukemia, Myeloid, Acute; Transplantation ConditioningAdolescent; Alberta; Busulfan; Child; Child, Preschool; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Humans; Infant; Male; Missouri; Texas; Treatment OutcomeSandler ES, Hagg R, Coppes MJ, Mustafa MM, Gamis A, Kamani N, Wall D. Hematopoietic stem cell transplantation (HSCT) with a conditioning regimen of busulfan, cyclophosphamide, and etoposide for children with acute myelogenous leukemia (AML): a phase I study of the Pediatric Blood and Marrow Transplant Consortium. Med Pediatr Oncol. 2000 Oct; 35(4):403-9.Med Pediatr Oncol2000-10-01T00:00:002000Hematopoietic stem cell transplantation (HSCT) with a conditioning regimen of busulfan, cyclophosphamide, and etoposide for children with acute myelogenous leukemia (AML): a phase I study of the Pediatric Blood and Marrow Transplant Consortium.cmhprofilesont:personsuffixperson suffixprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:hasSubjectAreaMajorTopicListhas major subject area listprns:hasSubjectAreaMinorTopicListhas minor subject area listprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed Identifiervivo:authorRankauthor rank in publicationAuthorshipDepartmentDivisionvivo:hasSubjectAreahas subject areavivo:hrJobTitleHR job titleInformation Resourcevivo:informationResourceInAuthorshipauthorsvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:orcidIdORCID idPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonD008297Physiology11633280.54802MaleD008923Geographic Areas39780.968769MissouriD013781Geographic Areas13170.995023TexasD015470Disorders81140.899415Leukemia, Myeloid, AcuteD016896Concepts & Ideas826670.820931Treatment OutcomeD018380Procedures19510.929369Hematopoietic Stem Cell TransplantationD018572Concepts & Ideas10450.98687Disease-Free SurvivalD019172Procedures240.998703Transplantation ConditioningMD, MPHAlanGamisAlan S. Gamis0.000000000000000.0000000000000049Gamis, Alan0000-0003-1513-2893Chief, Section of OncologyAuthorship 283950.04910520.04910521authors10.2520has subject areaD000293Living Beings10621370.61882AdolescentPediatricsClinicalChildren's Mercy Kansas CityD000416Geographic Areas110.999939AlbertaD000971Procedures14710.937832Antineoplastic Combined Chemotherapy ProtocolsD002066Chemicals & Drugs140.998493Busulfantrue1Chief, Section of OncologyChief, Section of OncologyD002648Living Beings11632570.520082ChildD002675Living Beings10415030.693171Child, PreschoolD003520Chemicals & Drugs780.997395CyclophosphamideD004334Concepts & Ideas24410.98302Drug Administration ScheduleD005047Chemicals & Drugs4110.993602EtoposideD005260Physiology11835990.534568FemaleD006801Living Beings12067970.397999HumansD007223Living Beings9914490.693714Infant